Please provide your email address to receive an email when new articles are posted on . A Bay Area bioelectronic medicine company announced the commercial launch of its next-generation Cala kIQ System ...
Encora Therapeutics announced today that it has received FDA 510(k) clearance for its Encora X1 wrist-worn device.
Noninvasive peripheral nerve stimulation applied repeatedly at home over a 3-month period reduced hand tremors in patients with essential tremor (ET), new research shows. In a large prospective study, ...
BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, today reported data demonstrating the increasing prevalence ...
Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device ...
The Encora X1 utilizes proprietary algorithms to analyze a patient’s tremor in real time. It delivers targeted stimulation to the wrist, modulating the neural pathways responsible for the tremor. The ...
Robots hold promise for a large number of people with neurological movement disorders severely affecting the quality of their lives. Now researchers have tapped artificial intelligence techniques to ...
Doctors at Henry Ford Hospital are using a new, incision-free brain treatment that can virtually eliminate a tremor in real ...
BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, announced that the U.S. Food and Drug Administration (FDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results